Your browser is not supported for the Live Clock Timer, please visit the Support Center for support.

Covid-19 disrupts NCD treatment,globally

M.Rajesh

 People with noncommunicable diseases including diabetes, cancer, cardiovascular disease or a chronic respiratory disease are more vulnerable to Covid-19.

One of the areas in which health services have been particularly affected is in care for people with noncommunicable diseases including diabetes, cancer, cardiovascular disease or a chronic respiratory disease.

It was dislosed by the  World Health Organization’s Director General Tedros Adhanom in a virtual press conference.

We already know that people living with NCDs are more vulnerable to becoming severely ill or dying from COVID-19.

At the same time, many people living with noncommunicable diseases are no longer able to access the medicines that they need.

WHO conducted a rapid assessment of service delivery for NCDs during the COVID-19 pandemic with 155 countries submitting data.

The results released today show that more than half of the countries surveyed have partially or completely disrupted services for treatment of hypertension; half for treatment of diabetes and related complications; and 42% for cancer treatment, and 31% for cardiovascular emergencies.  

Rehabilitation services have been disrupted in almost two-thirds of countries.

The COVID-19 response must therefore be inclusive of the health-care needs of people living with noncommunicable diseases.

Tobacco and NCDs 

One of the main causes of NCDs is tobacco.

This year’s WHO’s World No Tobacco Day focused on reaching young people to educate them on tobacco industry tactics used to manipulate them into using deadly products that kill 8 million people every year.

Even during this global pandemic, where we know tobacco puts users at a higher risk of severe disease and death, the tobacco and nicotine industry persist with their dangerous marketing tactics that aim to attract new users.

 

More News from City Talk